These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 26845137)
1. Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy. Biello F; Burrafato G; Rijavec E; Genova C; Barletta G; Truini A; Coco S; Bello MG; Alama A; Boccardo F; Grossi F Anticancer Agents Med Chem; 2016; 16(9):1142-54. PubMed ID: 26845137 [TBL] [Abstract][Full Text] [Related]
2. Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer. Rijavec E; Genova C; Barletta G; Biello F; Rossi G; Tagliamento M; Dal Bello MG; Coco S; Vanni I; Boccardo S; Alama A; Grossi F Expert Opin Investig Drugs; 2017 May; 26(5):551-561. PubMed ID: 28388262 [TBL] [Abstract][Full Text] [Related]
3. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression. Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034 [TBL] [Abstract][Full Text] [Related]
4. [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer]. Dong M; Li T; Chen J Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):116-120. PubMed ID: 29526179 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors. Salgia R Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160 [TBL] [Abstract][Full Text] [Related]
6. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts. Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress. Giacomini A; Taranto S; Rezzola S; Matarazzo S; Grillo E; Bugatti M; Scotuzzi A; Guerra J; Di Trani M; Presta M; Ronca R Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317057 [TBL] [Abstract][Full Text] [Related]
8. Targeting the MET gene for the treatment of non-small-cell lung cancer. Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409 [TBL] [Abstract][Full Text] [Related]
9. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer. Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992 [TBL] [Abstract][Full Text] [Related]
10. Targeting fibroblast growth factor receptor pathway in breast cancer. Criscitiello C; Esposito A; De Placido S; Curigliano G Curr Opin Oncol; 2015 Nov; 27(6):452-6. PubMed ID: 26397764 [TBL] [Abstract][Full Text] [Related]
11. Recent developments and advances of FGFR as a potential target in cancer. Xue WJ; Li MT; Chen L; Sun LP; Li YY Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580 [TBL] [Abstract][Full Text] [Related]
12. FGFR Signaling as a Target for Lung Cancer Therapy. Desai A; Adjei AA J Thorac Oncol; 2016 Jan; 11(1):9-20. PubMed ID: 26762735 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition. Fischer H; Taylor N; Allerstorfer S; Grusch M; Sonvilla G; Holzmann K; Setinek U; Elbling L; Cantonati H; Grasl-Kraupp B; Gauglhofer C; Marian B; Micksche M; Berger W Mol Cancer Ther; 2008 Oct; 7(10):3408-19. PubMed ID: 18852144 [TBL] [Abstract][Full Text] [Related]
14. Targeting the fibroblast growth factor receptor family in cancer. Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926 [TBL] [Abstract][Full Text] [Related]
15. FGFR as potential target in the treatment of squamous non small cell lung cancer. Tiseo M; Gelsomino F; Alfieri R; Cavazzoni A; Bozzetti C; De Giorgi AM; Petronini PG; Ardizzoni A Cancer Treat Rev; 2015 Jun; 41(6):527-39. PubMed ID: 25959741 [TBL] [Abstract][Full Text] [Related]
16. Targeting FGFR in Squamous Cell Carcinoma of the Lung. Hashemi-Sadraei N; Hanna N Target Oncol; 2017 Dec; 12(6):741-755. PubMed ID: 28685321 [TBL] [Abstract][Full Text] [Related]
17. Targeted therapies for advanced non-small cell lung cancer. Starakis I; Nikolakopoulos A; Mazokopakis EE Comb Chem High Throughput Screen; 2012 Sep; 15(8):641-55. PubMed ID: 22409867 [TBL] [Abstract][Full Text] [Related]
18. Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling. Qin A; Johnson A; Ross JS; Miller VA; Ali SM; Schrock AB; Gadgeel SM J Thorac Oncol; 2019 Jan; 14(1):54-62. PubMed ID: 30267839 [TBL] [Abstract][Full Text] [Related]
19. Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma. Lim SM; Kim HR; Shim HS; Soo RA; Cho BC Future Oncol; 2013 Mar; 9(3):377-86. PubMed ID: 23469973 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors. Hierro C; Rodon J; Tabernero J Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]